GeneTx Biotherapeutics
-
US FDA grants fast track status to GTX-102 to treat angelman syndrome
56 0GeneTx Biotherapeutics LLC a startup biotechnology company, and Ultragenyx Pharmaceutical,…
Read more
GeneTx Biotherapeutics LLC a startup biotechnology company, and Ultragenyx Pharmaceutical,…
Read moreMedia error: Format(s) not supported or source(s) not found
Download File: https://pharmaleaders.tv/wp-content/uploads/2015/02/Padma_Shri_Dr_Shashank_Joshi_addressing_at_Pharmaleaders_2014_Summit.mp4?_=1Download File: https://pharmaleaders.tv/wp-content/uploads/2015/02/Padma_Shri_Dr_Shashank_Joshi_addressing_at_Pharmaleaders_2014_Summit.mp4?_=1